Who We Are!
Dennis is an organic chemist with extensive
experience in drug discovery and development. He
has been involved with several marketed drugs,
including the antipsychotic agent ziprasidone
(Geodon (TM)), the oral antibiotic sultamicillin and
other important new medications. More recently, he
held positions of increasing management and
supervisory responsibility within the
Pharmaceutical Sciences, Project Management and
Veterinary Sciences Departments.
Dennis is listed as an inventor on 18 US patents and
is a co-author of two peer-reviewed journal
articles. He is a member of the American Chemical
Society (ACS) and was a Captain in the USAF
Reserves (ret.).
Dennis M. Godek
MediSynergics, LLC
Harry is a medicinal chemist with broad experience in
drug discovery and development.   He co-discovered the
atypical antipsychotic drug
ziprasidone (Geodon (TM))
for the treatment of schizophrenia and mania, and the
novel serotonin-1D antagonist
elzasonan for the treatment
of depression. During his career, he also developed
expertise in the design of novel compounds for the
treatment of Central Nervous System disorders, including
schizophrenia, depression, and attention deficit
hyperactivity disorder (ADHD), as well as medications
to minimize the long-term complications of  chronic
diabetes; these efforts resulted in the nomination of five
additional development candidates.

Harry is listed as an inventor on 58 U.S. patents issued to
Pfizer Inc. and another 11 patents assigned to
MediSynergics.  He is also an author of 30 peer-
reviewed publications and has lectured at Fordham
University Law School in New York City and
was an
invited speaker at
the University of Iceland in Reykjavik.  
He served as an adjunct instructor of Medicinal
Chemistry at the University of St. Joseph in West
Hartford, CT from 1995 until 2007.

Harry was long term member of the American Chemical
Society (ACS).  In 2005, he received the ACS Regional
Industrial Innovati
on Award for his role in the discovery
of Geodon and in 2007 was further recognized as a
of Chemistry
" by the ACS at their Spring National
Meeting in Boston, MA.

was featured in:
     "A Quick Lift for the Blues" by Robert Langreth,
Forbes (August 2003).
    "Get Your Wonder Drugs" by John Miller, National
, February 24, 2003).
    "How an Idea Becomes a Drug: The Story of
" by Paul Choiniere, The Day (New London, CT
daily newspaper, June 8, 2001).
Harry R. Howard
Vice-President /CSO
MediSynergics, LLC